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What does this review add?  
 In this systematic review we have identified questionnaire format outcome 
measures which are patient or health professional reported, used in CRPS 
clinical trials since 2000, and those which have been developed specifically 
for a CRPS population.  
 Information gained will inform an international consortium project to define 
a core outcome measurement set for CRPS Clinical trials. 
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Abstract 
Background and Objective 
Complex Regional Pain Syndrome (CRPS) is a chronic pain condition, often triggered 
by trauma to a limb and characterised by sensory, motor, autonomic and trophic 
changes within the affected limb. Due to the multi-faceted nature of the condition 
there are a wide range of potential health outcome measures for use within CRPS 
related clinical trials. This aim of this systematic literature review was to identify 
which patient or health professional questionnaire format outcome measures have 
been used in CRPS specific clinical trials, and which of these have been developed 
specifically for use in CRPS populations.  Information gained from this review will 
inform an international consortium project to define a Core Outcome measurement 
set for CRPS Clinical trials.  
Databases and Data Treatment 
The electronic databases EMBASE, Medline, PsycInfo, CINAHL and LILACS were 
systematically searched from January 2000 until April 2014.  
Results   
104 full text papers were obtained with 68 questionnaire outcome measures 
identified. Five of these outcome measures were validated for CRPS. Of those 
outcome measures used since 2000, those addressing physical functioning were 
most prevalent. 
Conclusions   
Currently CRPS clinical trials use a wide range of outcome measures making the 
potential to synthesise evidence problematic. There is no internationally agreed core 
measurement set. This diversity of outcome measures demonstrates a clear need for 
the development of a core measurement set to be used in CRPS clinical trials. 
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Introduction 
Complex Regional Pain Syndrome (CRPS) is a chronic pain condition which 
predominantly occurs after trauma to a limb. Pain is disproportionate to the inciting 
injury and associated with motor, sensory, trophic and autonomic changes (Harden 
et al., 2010).  In many cases CRPS will resolve within the first 6-13 months as 
indicated in prospective studies (Bean et al., 2014), however approximately 15-20% 
of individuals will develop long term disability significantly affecting their quality of 
life (Field et al., 1992; Geertzen et al., 1998).  
 
CRPS clinical trials currently do not have a shared core measurement set of 
internationally agreed outcome measures. This lack of standardisation limits the 
value of the synthesis of clinical trial evidence and its translation to clinical practice 
(Tugwell et al., 2007; Boers et al., 2014; Macefield et al., 2014). The complex nature 
of the condition means researchers may consider a wide range of instruments to 
measure outcomes and, as a result, there is heterogeneity across studies. To address 
these challenges, an international consortium of patients, clinicians and researchers 
was established in 2013 (COMPACT*) to identify and agree a minimum core set of 
outcome measures to answer specific research questions agreed as internationally 
important for the advance of treatment of CRPS. Previous initiatives have advocated 
the use of core outcome measurement sets in pain and rheumatology clinical trials; 
Initiative on Methods Measurement and Pain Assessment in Clinical Trials 
(IMMPACT) and Outcome Measures in Rheumatology (OMERACT). Each initiative  
 
* COMPACT Core Outcome Measures for complex regional PAin syndrome Clinical 
Trials.  
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identifies a number of core domains which should be considered when establishing a 
core set of health outcome measures (Turk et al., 2003: Boers et al., 2014). The six 
IMMPACT domains (Turk et al., 2003) are listed below; 
 Pain 
 Physical functioning 
 Emotional functioning 
 Participant ratings of global improvement  
 Symptoms and adverse events 
 Participant disposition 
These are applicable to chronic pain clinical trials such as CRPS studies. The outcome 
measures identified from our literature search were mapped to the six IMMPACT 
domains to facilitate the selection of a core outcome measurement set thereby 
enabling future comparison across CRPS clinical trials. 
 
Two previously published systematic literature reviews have been conducted which 
identified and evaluated outcome measures used for CRPS clinical trials (Schasfoort 
et al., 2000; Packham et al., 2012). Schasfoort et al., (2000) classified the outcome 
measures used in research for CRPS type I in the context of rehabilitation medicine. 
Both questionnaire outcome measures and objective clinical measures were 
included and assessed for relevance and objectivity. The authors found most 
outcome measures focused on sensory, motor, trophic and autonomic impairments 
with fewer measuring functional and social outcomes. Packham et al.,(2012)  
conducted a systematic review of the literature which evaluated the psychometric 
properties of outcome measures used for CRPS. Of those identified, no tool was 
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found to have been fully assessed for the comprehensive range of psychometric 
properties, resulting in no specific tool being recommended by the author for use in 
CRPS.  
This presented systematic literature review was required to identify the potential 
range of health outcome measure questionnaires that could be included within the 
CRPS core outcome measurement set.  
 
METHODS 
Data sources and search strategy 
CRPS clinical trials were identified from January 2000 onwards. A comprehensive 
literature search was conducted by 2nd April 2014 using electronic databases; 
EMBASE, Medline, PsycInfo, CINAHL and LILACS. Search terms comprised the study 
population combined with intervention terms. The study population terms were 
informed by the key word Complex Regional Pain Syndrome and its acronyms, 
synonyms and truncations, listed in Appendix S1. CRPS Type I and II were included 
(without/with associated nerve damage). The terms were mapped to a thesaurus for 
completeness. Search terms to identify the clinical trials were informed by a 
Cochrane systematic review of interventions for treating pain and disability in adults 
with CRPS (O’Connell et al., 2013), consultation with an academic librarian and 
colleagues with expertise in the area . An intervention study was defined according 
to O’Connell et al., (2013) as; “any intervention aimed at treating pain or disability or 
both”. To capture clinical trials, the first 200 results of the study population search in 
EMBASE were reviewed and subject headings relating to study design classification 
identified. These terms were reviewed by the author and another researcher to 
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ensure comprehensiveness and then used to identify the clinical trials. Appendix S2 
lists the key terms. 
 
 
Selection criteria 
The following inclusion criteria were applied to the search results; 
1. Paper available in the English language  
2. Human subjects 
3. Primary data only  
4. Study population aged 18 and over 
5. Papers published from January 2000 until date of search 
6. Studies evaluating an intervention directed at CRPS 
7. Studies with more than one participant 
 
There were no restrictions on study design applied as the intention was to capture 
all questionnaire outcome measures used for CRPS clinical trials regardless of 
methodology. The inclusion criteria were applied using the limiters available on the 
database where possible, and then applied to the title and abstract. SG reviewed all 
search results except Medline (LJ). Papers were identified from 2000 onwards as 
around this time the International Association for the Study of Pain (IASP) criteria 
were validated for standardising diagnosis of CRPS (Bruehl et al., 1999). In addition, 
this builds on work in a similar area (Schasfoort et al., 2000). To ensure all clinical 
trials were captured and for completeness, the search results were checked against 
papers identified in previous systematic reviews (Cossins et al., 2013; O’Connell et 
al., 2013), an unpublished systematic literature review and Trauma RElated Neuronal 
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Dysfunction (TREND) publications; a Dutch clinical and academic consortium 
(accessed from http://www.trendconsortium.nl/research/publications).  
 
 
Identifying outcome measures 
The full text of each paper meeting the inclusion criteria was examined and all 
patient reported and health professional reported questionnaire outcome measures 
were identified. In instances where an instrument appeared to be referenced under 
different measure names, for example; Walking Ability Questionnaire (Roorda et al., 
2005b), Walking Questionnaire and the Walking Skills Questionnaire, further 
clarification was sought from academic papers or the author directly. Objective 
clinical measures were not captured for the purposes of this review. Where possible 
the aim and scope of each outcome measure was recorded, licence access 
restrictions if any, and the language options available; this information was for later 
use to inform the COMPACT project. 
 
Classification of CRPS clinical trials  
Clinical trials were classified according to the three core elements of CRPS treatment 
described by O’Connell et al., (2013); pain management, rehabilitation and 
psychological therapy. Each element incorporates many different therapeutic 
options; for example, pain management includes pharmacological approaches, 
surgical interventions and neuromodulation techniques, rehabilitation includes 
physiotherapy and occupational therapy, and psychological therapy includes 
education and cognitive behaviour therapy (O’Connell et al., 2013). The Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
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recommendations for reporting systematic literature reviews have not been used as 
the papers were not assessed for methodological quality (Moher et al., 2009). 
 
 
Application to domains 
The outcome measures identified were mapped to the six core IMMPACT domains to 
inform the future selection process of a final core measurement set for the 
COMPACT consortium. 
 
RESULTS 
Study selection  
Initial searches generated a total of 3591 records. After eligibility criteria were 
applied and duplicates removed, 133 papers remained. Papers were selected if the 
full text was available electronically or from the librarian, resulting in 104 papers 
being included in the review (Appendix S3 for a list of included papers). Figure 1 
depicts the process. Appendix S4 lists the papers we were unable to access in full 
text. The 104 papers were classified according to the three core elements of CRPS 
treatment described by O’Connell et al (O’Connell et al., 2013); pain management 
(n=82), rehabilitation (n=22) and psychological therapy (n=0). The clinical trials 
identified incorporated a broad range of methodologies including randomised 
controlled trials (RCT), open label studies, observational and pilot studies. 
Prospective and retrospective studies were included.  
 
INSERT FIGURE 1 HERE 
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Outcome Measures 
68 outcome measures were identified from the 104 papers included in the review 
(Table 1). Four measures were adapted specifically for CRPS; Brief Pain Inventory 
adapted for CRPS (van der Vusse et al., 2004), CRPS Limb Symptom Scale (Goebel et 
al., 2010) and global impression of change of CRPS signs and symptoms, both patient 
reported (Munts et al., 2009; Munts et al., 2010) and health professional reported 
(Munts et al., 2009; Munts et al., 2010; van der Plas et al., 2011; van der Plas et al., 
2013). 64 measures were generic. Five outcome measures were validated for CRPS; 
Radboud Skills Questionnaire (Oerlemans et al., 2000), Rising and Sitting 
Questionnaire (Roorda et al., 2005a), Walking Stairs Questionnaire (Roorda et al., 
2004), the Walking Ability Questionnaire (Roorda et al., 2005b) and the Neuropathic 
Pain Scale (Galer and Jensen 1997). 
 
INSERT TABLE 1 HERE 
 
Mapping to the IMMPACT domains 
The content of some of the identified outcome measures spanned more than one of 
the IMMPACT domains. For example, The Short Form-36 (Ware and Sherbourne 
1992) includes measures relating to physical functioning and mental health. For the 
purpose of this review a decision was made by the authors to classify outcome 
measures into the domain that best represented the majority of the outcome 
measure items. 
 
The number of studies included in this review which use each outcome measure is 
identified in brackets in the following text. 
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Pain 
Nineteen different outcome measures were identified for this domain. The most 
frequently used were the visual analogue scale (n= 53 studies) and numeric rating 
scale (n=33) which are used to assess pain intensity on a scale of 0-10. The McGill 
Pain questionnaire was also frequently used (n=24), assessing both intensity and 
quality of pain (Melzack 1975). Other pain measures were used much less frequently 
(≤ 5 studies for each measure) such as the Neuropathic Pain Scale (Galer and Jensen 
1997), Pain Disability Index (Pollard 1984) and Brief Pain Inventory (Cleeland 1989). 
All outcome measures identified in this domain were patient self-report. 
 
Physical Functioning 
Twenty-nine different outcome measures were used to capture physical functioning. 
Most frequently used were the EuroQol EQ-5D (EuroQol Group 1990) (n=11), 
Radboud Skills Questionnaire (Oerlemans et al., 2000) (n=10) and the Rising and 
Sitting Questionnaire (Roorda et al., 2005a) (n=10). The Short-Form 36 (Ware and 
Sherbourne 1992) (n=9), Walking Ability Questionnaire (Roorda et al., 2005b) (n=8) 
and the Disabilities of Arm, Shoulder and Hand questionnaire (Hudak et al., 1996) 
(n=6) were also used frequently. Many outcome measures were used in only one 
study , for example the International Physical Activity questionnaire (Sjöström et al., 
2002) and the Rivermead Mobility Index (Collen et al., 1991).  90% (n= 26) of 
outcome measures identified were patient reported. 
 
Emotional Functioning 
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Ten outcome measures were identified for this domain, five of which were designed 
to assess depression. Other measures included those used to measure an individual’s 
emotional response to pain, such as the Pain Anxiety Symptoms Scale (McCracken et 
al., 1992) and the Pain Catastrophizing Scale (Sullivan et al., 1995). The Tampa Scale 
for Kinesiophobia was the most widely used measure in the emotional functioning 
domain (n=4). This scale was originally designed to measure fear of movement 
related to lower back pain (Miller et al., 1991). All measures are patient reported 
except the Hamilton Rating Scale for Depression (Hamilton 1980) (n=1). 
 
Participant Rating of Global Improvement 
Eight outcome measures were identified for this domain. The most frequently used 
were the Patient Global Impression of Change questionnaire (PGIC) (n=6) and the 
Global Perceived Effect (n=6). Other measures included the PGIC of CRPS Signs and 
Symptoms (n=2) and Response to Treatment (n=1). One health professional rating 
scale was used in several studies; Clinician Rating of Global Impression of Change in 
CRPS Signs and Symptoms (n=4). Only one rehabilitation study reported using an 
outcome measure from this domain (Lagueux et al., 2012), with more frequent use 
demonstrated in studies relating to pain management. 
 
Symptoms and Adverse Events 
Two studies (Wallace et al., 2000; Kiefer et al.,2008) recorded the occurrence and 
intensity of side effects using a visual analogue scale (0-100mm). Participants were 
asked to rate any side effects which may occur as a result of the intervention; from 
no side effect to worst imaginable side effect or intolerable. 
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Patient disposition 
This domain includes those participants who withdrew from a study or who were 
lost to follow up. Although, it is acknowledged that these data are important to 
report, the studies identified within this literature review did not use questionnaire 
outcome measures to capture these data. 
 
DISCUSSION   
This systematic literature review provides a comprehensive summary of patient 
reported and health professional reported questionnaire outcome measures used in 
published CRPS intervention studies conducted between January 2000 and April 
2014. There is clear evidence of a shift in utilisation of outcome measures compared 
to the findings of previous work (Schasfoort et al., 2000). Prior to 2000 there was 
little emphasis on health outcomes related to daily functioning in the context of 
rehabilitation medicine. In the literature review by Schasfoort et al., (2000) the 
majority of outcome measures related to sensory, motor, trophic and autonomic 
impairments but in contrast, in this current review, outcome measures related to 
physical functioning comprised 43% of identified tools. Furthermore, some measures 
which were classified within other domains also incorporate aspects of physical 
functioning e.g. West Haven-Yale Multidimensional Pain Inventory (Kerns et al., 
1985). The change in diagnostic criteria since publication of the Schasfoort review 
(2000) may account for this change. Current IASP diagnostic criteria have a stronger 
emphasis on motor function which may have encouraged a greater focus on the 
assessment of physical function in recent studies.    
The studies included in this current review encompass a wide range of therapeutic 
interventions within the area of pain management and rehabilitation described by 
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O’Connell et al., (2013). Several studies investigated pain exposure therapy in a 
rehabilitation context and were therefore classified as rehabilitation rather than 
psychological interventions; confirmed by correspondence with the authors (Ek et 
al., 2009; van de Meent et al., 2011; Barnhoorn et al., 2012). The cross-over between 
the rehabilitation and psychological classification is acknowledged however with 
both approaches addressing aspects of the other. There was an absence of studies 
reporting other psychological interventions which was unexpected as these were 
recommended as best-practice in the IASP treatment algorithm and have been 
considered a core part of CRPS rehabilitation treatment for some time now (Stanton-
Hicks et al., 1998; Harden et al., 2013). National guidelines within the UK also 
advocate psychological interventions as one of the four pillars of care along with 
pharmacological, physical and vocational rehabilitation, and patient education/self-
management interventions (Goebel et al., 2012). 
The diversity of outcome measures identified across the research studies 
demonstrates the challenge of synthesising research evidence at a national or 
international level. The heterogeneity of outcome measures may compromise 
potential meta-analysis and interpretation of results demonstrating the need for 
more consistency across clinical trials (Duncan et al., 2000).  However, it is apparent 
that some instruments are utilised for several studies by the same researcher or 
research team, making within research group synthesis or across these specific 
research groups more feasible. In addition, there may be cultural factors which 
influence the selection of specific measures. Patient reported outcome measures 
developed for a particular cultural group may increase the response rate therefore 
influencing the choice of a particular measure, however validation for the specific 
population is required (Weldring and Smith 2013). Health professional reported 
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outcome measures comprised only 9% of those identified. These provide objective 
clinical judgements of the patient's signs, impairment and disability but cannot 
report symptoms and experiences only known to the patient (Black and Jenkinson 
2009). The prominence of patient reported outcomes is largely a consequence of 
clinical interventions aiming to improve aspects of the condition which can only be 
experienced and reported by the patient. In addition the nature of a chronic pain 
condition means objective measures of a patient’s pain experience are not available 
(Turk et al., 2006). As expected there are no health professional reported outcome 
measures identified in the pain domain within this review.  
Of the outcome measures identified in the review, only five were validated for CRPS; 
Radboud Skills Questionnaire (Oerlemans et al., 2000), Rising and Sitting 
Questionnaire (Roorda et al., 2005a), Walking Stairs Questionnaire (Roorda et al., 
2004), the Walking Ability Questionnaire (Roorda et al., 2005b)  and the Neuropathic 
Pain Scale (Galer and Jensen 1997). This indicates a need for further disease specific 
measures to be validated as they provide greater face validity and credibility than 
generic measures (Black 2013). 
 
Limitations/Risk of Bias 
This review was not without limitations. Papers were confined to English language 
only as translation services were unavailable. The literature search was reviewed 
predominantly by one researcher (SG) except Medline (SG and LJ). Access to full text 
papers was limited by availability of online resources via electronic databases. The 
academic library was unable to provide unlimited support to access additional 
papers as no specific funding was available for this. The full text of 29 papers was 
unobtainable for these reasons and there is a possibility that outcome measures not 
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previously identified may be included in these papers. No intervention studies were 
identified relating to psychological therapy and consideration should be given to 
revisiting the search strategy in collaboration with a psychologist to confirm the 
search result.  
 
 
Conclusion 
A broad range of patient reported outcome measures are used to evaluate the 
impact of interventions for CRPS, with fewer utilised outcome measures being health 
professional reported. This diversity of outcome measures demonstrates a clear 
need for the development of a specific CRPS core outcome measurement set to 
facilitate the synthesis of evidence, particularly in this relatively rare condition which 
would benefit from large scale studies. 
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